174 related articles for article (PubMed ID: 16039870)
1. Multistep skin cancer in mice as a model to study the evolution of cancer cells.
Kemp CJ
Semin Cancer Biol; 2005 Dec; 15(6):460-73. PubMed ID: 16039870
[TBL] [Abstract][Full Text] [Related]
2. Induction of invasive mouse skin carcinomas in transgenic mice with mutations in both H-ras and p53.
Zhang Z; Yao R; Li J; Wang Y; Boone CW; Lubet RA; You M
Mol Cancer Res; 2005 Oct; 3(10):563-74. PubMed ID: 16254190
[TBL] [Abstract][Full Text] [Related]
3. Genetic models of human cancer as a multistep process. Paradigm models of colorectal cancer, breast cancer, and chronic myelogenous and acute lymphoblastic leukaemia.
Karakosta A; Golias Ch; Charalabopoulos A; Peschos D; Batistatou A; Charalabopoulos K
J Exp Clin Cancer Res; 2005 Dec; 24(4):505-14. PubMed ID: 16471312
[TBL] [Abstract][Full Text] [Related]
4. Ras mutation promotes p53 activation and apoptosis of skin keratinocytes.
Zhao Y; Chaiswing L; Bakthavatchalu V; Oberley TD; St Clair DK
Carcinogenesis; 2006 Aug; 27(8):1692-8. PubMed ID: 16613839
[TBL] [Abstract][Full Text] [Related]
5. Ischemia-induced K-ras mutations in human colorectal cancer cells: role of microenvironmental regulation of MSH2 expression.
Shahrzad S; Quayle L; Stone C; Plumb C; Shirasawa S; Rak JW; Coomber BL
Cancer Res; 2005 Sep; 65(18):8134-41. PubMed ID: 16166287
[TBL] [Abstract][Full Text] [Related]
6. Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras mediated transformation.
Konishi H; Karakas B; Abukhdeir AM; Lauring J; Gustin JP; Garay JP; Konishi Y; Gallmeier E; Bachman KE; Park BH
Cancer Res; 2007 Sep; 67(18):8460-7. PubMed ID: 17875684
[TBL] [Abstract][Full Text] [Related]
7. Molecular events associated with arsenic-induced malignant transformation of human prostatic epithelial cells: aberrant genomic DNA methylation and K-ras oncogene activation.
Benbrahim-Tallaa L; Waterland RA; Styblo M; Achanzar WE; Webber MM; Waalkes MP
Toxicol Appl Pharmacol; 2005 Aug; 206(3):288-98. PubMed ID: 16039940
[TBL] [Abstract][Full Text] [Related]
8. Cellular aspects of photocarcinogenesis.
Nishigori C
Photochem Photobiol Sci; 2006 Feb; 5(2):208-14. PubMed ID: 16465307
[TBL] [Abstract][Full Text] [Related]
9. Populations of p53 codon 270 CGT to TGT mutant cells in SKH-1 mouse skin tumors induced by simulated solar light.
Verkler TL; Delongchamp RR; Couch LH; Miller BJ; Warbritton A; Mellick PW; Howard PC; Parsons BL
Mol Carcinog; 2008 Nov; 47(11):822-34. PubMed ID: 18381587
[TBL] [Abstract][Full Text] [Related]
10. Dual role of inactivating Lef1 mutations in epidermis: tumor promotion and specification of tumor type.
Niemann C; Owens DM; Schettina P; Watt FM
Cancer Res; 2007 Apr; 67(7):2916-21. PubMed ID: 17409394
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.
Muñoz NM; Upton M; Rojas A; Washington MK; Lin L; Chytil A; Sozmen EG; Madison BB; Pozzi A; Moon RT; Moses HL; Grady WM
Cancer Res; 2006 Oct; 66(20):9837-44. PubMed ID: 17047044
[TBL] [Abstract][Full Text] [Related]
12. [Prevention of cancer and the dose-effect relationship: the carcinogenic effects of ionizing radiations].
Tubiana M
Cancer Radiother; 2009 Jul; 13(4):238-58. PubMed ID: 19539515
[TBL] [Abstract][Full Text] [Related]
13. A genetic progression model of oral cancer: current evidence and clinical implications.
Braakhuis BJ; Leemans CR; Brakenhoff RH
J Oral Pathol Med; 2004 Jul; 33(6):317-22. PubMed ID: 15200478
[TBL] [Abstract][Full Text] [Related]
14. Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis.
Honeycutt KA; Chen Z; Koster MI; Miers M; Nuchtern J; Hicks J; Roop DR; Shohet JM
Oncogene; 2006 Jul; 25(29):4027-32. PubMed ID: 16518415
[TBL] [Abstract][Full Text] [Related]
15. Natural selection in neoplastic progression of Barrett's esophagus.
Maley CC; Reid BJ
Semin Cancer Biol; 2005 Dec; 15(6):474-83. PubMed ID: 16043360
[TBL] [Abstract][Full Text] [Related]
16. Analysis of tumor progression by transcriptional profiling of mouse MK16 cell lines transformed with human papillomavirus type 16 E6 and E7 oncogenes and activated H-ras.
Smahel M; Smahelová J; Tejklová P; Tachezy R; Jelínek F
Oncol Rep; 2005 Dec; 14(6):1665-74. PubMed ID: 16273273
[TBL] [Abstract][Full Text] [Related]
17. Localization of a mutant p53 response element on the tissue inhibitor of metalloproteinase-3 promoter: mutant p53 activities are distinct from wild-type.
Thomas S; Reisman D
Cancer Lett; 2006 Aug; 240(1):48-59. PubMed ID: 16236433
[TBL] [Abstract][Full Text] [Related]
18. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R
J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218
[TBL] [Abstract][Full Text] [Related]
19. The population dynamics of cancer: a Darwinian perspective.
Vineis P; Berwick M
Int J Epidemiol; 2006 Oct; 35(5):1151-9. PubMed ID: 16987840
[TBL] [Abstract][Full Text] [Related]
20. Recursive causality in evolution: a model for epigenetic mechanisms in cancer development.
Haslberger A; Varga F; Karlic H
Med Hypotheses; 2006; 67(6):1448-54. PubMed ID: 16844314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
